| Year |
Citation |
Score |
| 2023 |
Serra V, Aroni S, Bortolato M, Frau R, Melis M. Endocannabinoid-dependent decrease of GABAergic transmission on dopaminergic neurons is associated with susceptibility to cocaine stimulant effects in pre-adolescent male MAOA hypomorphic mice exposed to early life stress. Neuropharmacology. 233: 109548. PMID 37080337 DOI: 10.1016/j.neuropharm.2023.109548 |
0.786 |
|
| 2023 |
Santoni M, Sagheddu C, Serra V, Mostallino R, Paola Castelli M, Pisano F, Scherma M, Fadda P, Muntoni AL, Zamberletti E, Rubino T, Melis M, Pistis M. Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring. Brain, Behavior, and Immunity. PMID 36746342 DOI: 10.1016/j.bbi.2023.02.002 |
0.837 |
|
| 2021 |
Sagheddu C, Melis M, Muntoni AL, Pistis M. Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders. Pharmaceuticals (Basel, Switzerland). 14. PMID 34681249 DOI: 10.3390/ph14101025 |
0.769 |
|
| 2021 |
Ciccocioppo R, Guglielmo G, Li H, Melis M, Caffino L, Shen Q, Domi A, Fumagalli F, Demopulos GA, Gaitanaris GA. Selective inhibition of phosphodiesterase 7 enzymes reduces motivation for nicotine use through modulation of mesolimbic dopaminergic transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 34083258 DOI: 10.1523/JNEUROSCI.3180-20.2021 |
0.47 |
|
| 2021 |
Porcu A, Mostallino R, Serra V, Melis M, Sogos V, Beggiato S, Ferraro L, Manetti F, Gianibbi B, Bettler B, Corelli F, Mugnaini C, Castelli MP. COR758, a negative allosteric modulator of GABA receptors. Neuropharmacology. 189: 108537. PMID 33798546 DOI: 10.1016/j.neuropharm.2021.108537 |
0.761 |
|
| 2021 |
Traccis F, Serra V, Sagheddu C, Congiu M, Saba P, Giua G, Devoto P, Frau R, Cheer JF, Melis M. Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats. International Journal of Molecular Sciences. 22. PMID 33562259 DOI: 10.3390/ijms22041666 |
0.807 |
|
| 2020 |
Murru E, Carta G, Manca C, Sogos V, Pistis M, Melis M, Banni S. Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation. Frontiers in Pharmacology. 11: 587140. PMID 33505308 DOI: 10.3389/fphar.2020.587140 |
0.6 |
|
| 2020 |
Sagheddu C, Traccis F, Serra V, Congiu M, Frau R, Cheer JF, Melis M. Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 105: 110128. PMID 33031862 DOI: 10.1016/j.pnpbp.2020.110128 |
0.826 |
|
| 2019 |
Frau R, Miczán V, Traccis F, Aroni S, Pongor CI, Saba P, Serra V, Sagheddu C, Fanni S, Congiu M, Devoto P, Cheer JF, Katona I, Melis M. Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone. Nature Neuroscience. PMID 31611707 DOI: 10.1038/S41593-019-0512-2 |
0.781 |
|
| 2019 |
Cadoni C, De Felice M, Corongiu S, Dessì C, Espa E, Melis M, Fenu S. Role of genetic background in the effects of adolescent nicotine exposure on mesolimbic dopamine transmission. Addiction Biology. e12803. PMID 31342609 DOI: 10.1111/adb.12803 |
0.505 |
|
| 2019 |
Frau R, Fanni S, Serra V, Simola N, Godar S, Traccis F, Devoto P, Bortolato M, Melis M. Dysfunctional mesocortical dopamine circuit at pre-adolescence is associated to aggressive behavior in MAO-A hypomorphic mice exposed to early life stress. Neuropharmacology. PMID 30738037 DOI: 10.1016/J.Neuropharm.2019.01.032 |
0.817 |
|
| 2019 |
Godar SC, Mosher LJ, Scheggi S, Devoto P, Moench KM, Strathman HJ, Jones CM, Frau R, Melis M, Gambarana C, Wilkinson B, DeMontis MG, Fowler SC, Coba MP, Wellman CL, et al. Gene-environment interactions in antisocial behavior are mediated by early-life 5-HT receptor activation. Neuropharmacology. PMID 30716416 DOI: 10.1016/J.Neuropharm.2019.01.028 |
0.405 |
|
| 2018 |
De Felice M, Melis M, Aroni S, Muntoni AL, Fanni S, Frau R, Devoto P, Pistis M. The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia. Cns Neuroscience & Therapeutics. PMID 30461214 DOI: 10.1111/cns.13087 |
0.786 |
|
| 2018 |
Secci ME, Mascia P, Sagheddu C, Beggiato S, Melis M, Borelli AC, Tomasini MC, Panlilio LV, Schindler CW, Tanda G, Ferré S, Bradberry CW, Ferraro L, Pistis M, Goldberg SR, et al. Astrocytic Mechanisms Involving Kynurenic Acid Control Δ-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas. Molecular Neurobiology. PMID 30151725 DOI: 10.1007/s12035-018-1319-y |
0.721 |
|
| 2018 |
Porcu A, Melis M, Turecek R, Ullrich C, Mocci I, Bettler B, Gessa GL, Castelli MP. Rimonabant, a potent CB1 cannabinoid receptor antagonist, is a Gαi/o protein inhibitor. Neuropharmacology. 133: 107-120. PMID 29407764 DOI: 10.1016/J.Neuropharm.2018.01.024 |
0.493 |
|
| 2017 |
Sørensen AT, Ledri M, Melis M, Nikitidou Ledri L, Andersson M, Kokaia M. Altered Chloride Homeostasis Decreases the Action Potential Threshold and Increases Hyperexcitability in Hippocampal Neurons. Eneuro. 4. PMID 29379872 DOI: 10.1523/ENEURO.0172-17.2017 |
0.45 |
|
| 2017 |
Diana M, Raij T, Melis M, Nummenmaa A, Leggio L, Bonci A. Rehabilitating the addicted brain with transcranial magnetic stimulation. Nature Reviews. Neuroscience. PMID 28951609 DOI: 10.1038/Nrn.2017.113 |
0.712 |
|
| 2017 |
Puligheddu M, Melis M, Pillolla G, Milioli G, Parrino L, Terzano GM, Aroni S, Sagheddu C, Marrosu F, Pistis M, Muntoni AL. Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. Epilepsia. PMID 28766701 DOI: 10.1111/epi.13863 |
0.76 |
|
| 2016 |
Scheggi S, Melis M, De Felice M, Aroni S, Muntoni AL, Pelliccia T, Gambarana C, De Montis MG, Pistis M. PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors. Neuropharmacology. 110: 251-259. PMID 27457507 DOI: 10.1016/j.neuropharm.2016.07.024 |
0.816 |
|
| 2016 |
Fattore L, Melis M. Editorial: Exploring Gender and Sex Differences in Behavioral Dyscontrol: From Drug Addiction to Impulse Control Disorders. Frontiers in Psychiatry. 7: 19. PMID 26941657 DOI: 10.3389/Fpsyt.2016.00019 |
0.41 |
|
| 2016 |
Fattore L, Melis M. Sex differences in impulsive and compulsive behaviors: a focus on drug addiction. Addiction Biology. PMID 26935237 DOI: 10.1111/Adb.12381 |
0.42 |
|
| 2016 |
Luchicchi A, Lecca S, Melis M, De Felice M, Cadeddu F, Frau R, Muntoni AL, Fadda P, Devoto P, Pistis M. Maternal immune activation disrupts dopamine system in the offspring. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26819283 DOI: 10.1093/Ijnp/Pyw007 |
0.79 |
|
| 2016 |
Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M. Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives. Psychopharmacology. PMID 26728894 DOI: 10.1007/S00213-015-4196-3 |
0.754 |
|
| 2015 |
Sagheddu C, Muntoni AL, Pistis M, Melis M. Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function. International Review of Neurobiology. 125: 257-302. PMID 26638769 DOI: 10.1016/bs.irn.2015.10.004 |
0.805 |
|
| 2015 |
De Luca MA, Bimpisidis Z, Melis M, Marti M, Caboni P, Valentini V, Margiani G, Pintori N, Polis I, Marsicano G, Parsons LH, Di Chiara G. Stimulation of in vivo dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid. Neuropharmacology. 99: 705-714. PMID 26327678 DOI: 10.1016/J.Neuropharm.2015.08.041 |
0.605 |
|
| 2015 |
Sanna F, Contini A, Melis MR, Argiolas A. Role of dopamine D4 receptors in copulatory behavior: Studies with selective D4 agonists and antagonists in male rats. Pharmacology, Biochemistry, and Behavior. 137: 110-8. PMID 26287845 DOI: 10.1016/j.pbb.2015.08.012 |
0.623 |
|
| 2015 |
Sagheddu C, Aroni S, De Felice M, Lecca S, Luchicchi A, Melis M, Muntoni AL, Romano R, Palazzo E, Guida F, Maione S, Pistis M. Enhanced serotonin and mesolimbic dopamine transmissions in a rat model of neuropathic pain. Neuropharmacology. 97: 383-93. PMID 26113399 DOI: 10.1016/J.Neuropharm.2015.06.003 |
0.81 |
|
| 2015 |
Sagheddu C, Melis M. Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system. Cns & Neurological Disorders Drug Targets. 14: 502-17. PMID 25714966 DOI: 10.2174/1871527314666150225143748 |
0.574 |
|
| 2015 |
de Guglielmo G, Melis M, De Luca MA, Kallupi M, Li HW, Niswender K, Giordano A, Senzacqua M, Somaini L, Cippitelli A, Gaitanaris G, Demopulos G, Damadzic R, Tapocik J, Heilig M, et al. PPARc activation attenuates opioid consumption and modulates mesolimbic dopamine transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1052. PMID 25668637 DOI: 10.1038/Npp.2014.305 |
0.612 |
|
| 2015 |
Dudok B, Barna L, Ledri M, Szabó SI, Szabadits E, Pintér B, Woodhams SG, Henstridge CM, Balla GY, Nyilas R, Varga C, Lee SH, Matolcsi M, Cervenak J, Kacskovics I, ... ... Melis M, et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nature Neuroscience. 18: 75-86. PMID 25485758 DOI: 10.1038/Nn.3892 |
0.65 |
|
| 2015 |
de Guglielmo G, Melis M, De Luca MA, Kallupi M, Li HW, Niswender K, Giordano A, Senzacqua M, Somaini L, Cippitelli A, Gaitanaris G, Demopulos G, Damadzic R, Tapocik J, Heilig M, et al. PPARγ activation attenuates opioid consumption and modulates mesolimbic dopamine transmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 927-37. PMID 25311134 DOI: 10.1038/npp.2014.268 |
0.548 |
|
| 2015 |
Melis M, Carboni E, Caboni P, Acquas E. Key role of salsolinol in ethanol actions on dopamine neuronal activity of the posterior ventral tegmental area. Addiction Biology. 20: 182-93. PMID 24103023 DOI: 10.1111/adb.12097 |
0.509 |
|
| 2015 |
Melis M, Colombo G, Pistis M. SY02-3ENDOCANNABINOID-MEDIATED PLASTICITY AT INHIBITORY SYNAPSES ONTO DOPAMINE NEURONS AS A POSSIBLE MARKER OF INNATE PREFERENCE TO ALCOHOL Alcohol and Alcoholism. 50: i3.3-i4. DOI: 10.1093/ALCALC/AGV076.06 |
0.751 |
|
| 2015 |
Georges F, Melis M. Cannabinoid-dopamine interactions: Modulation of midbrain DA neurons by endocannabinoids Cannabinoid Modulation of Emotion, Memory, and Motivation. 443-470. DOI: 10.1007/978-1-4939-2294-9_17 |
0.516 |
|
| 2014 |
Melis M, Sagheddu C, De Felice M, Casti A, Madeddu C, Spiga S, Muntoni AL, Mackie K, Marsicano G, Colombo G, Castelli MP, Pistis M. Enhanced endocannabinoid-mediated modulation of rostromedial tegmental nucleus drive onto dopamine neurons in Sardinian alcohol-preferring rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12716-24. PMID 25232109 DOI: 10.1523/Jneurosci.1844-14.2014 |
0.816 |
|
| 2014 |
Fattore L, Melis M, Fadda P, Fratta W. Sex differences in addictive disorders. Frontiers in Neuroendocrinology. 35: 272-84. PMID 24769267 DOI: 10.1016/J.Yfrne.2014.04.003 |
0.407 |
|
| 2014 |
Melis M, Pistis M. Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 86: 42-9. PMID 24704146 DOI: 10.1016/j.phrs.2014.03.009 |
0.673 |
|
| 2014 |
Berglind F, Ledri M, Sørensen AT, Nikitidou L, Melis M, Bielefeld P, Kirik D, Deisseroth K, Andersson M, Kokaia M. Optogenetic inhibition of chemically induced hypersynchronized bursting in mice. Neurobiology of Disease. 65: 133-41. PMID 24491965 DOI: 10.1016/J.Nbd.2014.01.015 |
0.435 |
|
| 2014 |
Melis M. S.16.03 Subgroups of midbrain dopamine neurons exhibit discrete expression of endocannabinoid-mediated plasticity European Neuropsychopharmacology. 24: S132. DOI: 10.1016/S0924-977X(14)70178-6 |
0.503 |
|
| 2013 |
Melis M, De Felice M, Lecca S, Fattore L, Pistis M. Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats. Frontiers in Integrative Neuroscience. 7: 93. PMID 24416004 DOI: 10.3389/Fnint.2013.00093 |
0.749 |
|
| 2013 |
Puligheddu M, Pillolla G, Melis M, Lecca S, Marrosu F, De Montis MG, Scheggi S, Carta G, Murru E, Aroni S, Muntoni AL, Pistis M. PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings. Plos One. 8: e64541. PMID 23724059 DOI: 10.1371/journal.pone.0064541 |
0.779 |
|
| 2013 |
Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, et al. PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6203-11. PMID 23554501 DOI: 10.1523/Jneurosci.4647-12.2013 |
0.764 |
|
| 2013 |
Melis M, Carta G, Pistis M, Banni S. Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. Cns & Neurological Disorders Drug Targets. 12: 70-7. PMID 23394525 DOI: 10.2174/1871527311312010012 |
0.742 |
|
| 2013 |
Sagheddu C, Melis M, De Felice M, Colombo G, Pistis M. S.07.03 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction European Neuropsychopharmacology. 23: S120-S121. DOI: 10.1016/S0924-977X(13)70147-0 |
0.655 |
|
| 2013 |
Sagheddu C, Melis M, Pistis M. P.1.024 Endocannabinoid-mediated plasticity at inhibitory synapses on dopamine cells as a marker of vulnerability to addiction European Neuropsychopharmacology. 23: S22-S23. DOI: 10.1016/S0924-977X(13)70026-9 |
0.652 |
|
| 2012 |
Melis M, Pistis M. Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 367: 3276-85. PMID 23108546 DOI: 10.1098/rstb.2011.0383 |
0.75 |
|
| 2012 |
Bortolato M, Godar SC, Melis M, Soggiu A, Roncada P, Casu A, Flore G, Chen K, Frau R, Urbani A, Castelli MP, Devoto P, Shih JC. NMDARs mediate the role of monoamine oxidase A in pathological aggression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8574-82. PMID 22723698 DOI: 10.1523/Jneurosci.0225-12.2012 |
0.426 |
|
| 2012 |
Melis M, Muntoni AL, Pistis M. Endocannabinoids and the processing of value-related signals. Frontiers in Pharmacology. 3: 7. PMID 22347186 DOI: 10.3389/fphar.2012.00007 |
0.824 |
|
| 2012 |
Lecca S, Melis M, Luchicchi A, Muntoni AL, Pistis M. Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1164-76. PMID 22169942 DOI: 10.1038/Npp.2011.302 |
0.84 |
|
| 2011 |
Lecca S, Melis M, Luchicchi A, Ennas MG, Castelli MP, Muntoni AL, Pistis M. Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 589-602. PMID 21048703 DOI: 10.1038/Npp.2010.190 |
0.836 |
|
| 2010 |
Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M. Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. Biological Psychiatry. 68: 256-64. PMID 20570248 DOI: 10.1016/J.Biopsych.2010.04.016 |
0.743 |
|
| 2010 |
Fattore L, Melis M, Fadda P, Pistis M, Fratta W. The endocannabinoid system and nondrug rewarding behaviours. Experimental Neurology. 224: 23-36. PMID 20353776 DOI: 10.1016/J.Expneurol.2010.03.020 |
0.666 |
|
| 2010 |
Pistis M, Melis M. From surface to nuclear receptors: the endocannabinoid family extends its assets. Current Medicinal Chemistry. 17: 1450-67. PMID 20166922 DOI: 10.2174/092986710790980014 |
0.636 |
|
| 2010 |
Lecca S, Luchicchi A, Carta S, Melis M, Muntoni A, Pistis M. P.6.d.018 Cocaine, morphine and the cannabinoid win55212 depress neuronal activity in the rostromedial tegmental nucleus European Neuropsychopharmacology. 20: S598. DOI: 10.1016/S0924-977X(10)70912-3 |
0.644 |
|
| 2009 |
Melis M, Diana M, Enrico P, Marinelli M, Brodie MS. Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress. Alcohol (Fayetteville, N.Y.). 43: 531-9. PMID 19913196 DOI: 10.1016/J.Alcohol.2009.05.004 |
0.717 |
|
| 2009 |
Wanat MJ, Sparta DR, Hopf FW, Bowers MS, Melis M, Bonci A. Strain specific synaptic modifications on ventral tegmental area dopamine neurons after ethanol exposure. Biological Psychiatry. 65: 646-53. PMID 19118821 DOI: 10.1016/j.biopsych.2008.10.042 |
0.792 |
|
| 2009 |
Melis M, Pillolla G, Perra S, Colombo G, Muntoni AL, Pistis M. Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats. Psychopharmacology. 201: 471-81. PMID 18777018 DOI: 10.1007/s00213-008-1309-2 |
0.811 |
|
| 2008 |
Melis M, Pillolla G, Luchicchi A, Muntoni AL, Yasar S, Goldberg SR, Pistis M. Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13985-94. PMID 19091987 DOI: 10.1523/Jneurosci.3221-08.2008 |
0.818 |
|
| 2008 |
Diana M, Peana AT, Sirca D, Lintas A, Melis M, Enrico P. Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system. Annals of the New York Academy of Sciences. 1139: 307-17. PMID 18991876 DOI: 10.1196/Annals.1432.009 |
0.814 |
|
| 2007 |
Melis M, Pistis M. Endocannabinoid signaling in midbrain dopamine neurons: more than physiology? Current Neuropharmacology. 5: 268-77. PMID 19305743 DOI: 10.2174/157015907782793612 |
0.749 |
|
| 2007 |
Melis M, Enrico P, Peana AT, Diana M. Acetaldehyde mediates alcohol activation of the mesolimbic dopamine system. The European Journal of Neuroscience. 26: 2824-33. PMID 18001279 DOI: 10.1111/j.1460-9568.2007.05887.x |
0.75 |
|
| 2007 |
Pillolla G, Melis M, Perra S, Muntoni AL, Gessa GL, Pistis M. Medial forebrain bundle stimulation evokes endocannabinoid-mediated modulation of ventral tegmental area dopamine neuron firing in vivo. Psychopharmacology. 191: 843-53. PMID 17334799 DOI: 10.1007/s00213-007-0733-z |
0.853 |
|
| 2007 |
Pillolla G, Perra S, Melis M, Muntoni A, Pistis M. P.1.20 Medial forebrain bundle stimulation induces changes in dopamine neuron activity: role of endocannabinoids and glutamate European Neuropsychopharmacology. 17: S18. DOI: 10.1016/S0924-977X(07)70021-4 |
0.811 |
|
| 2006 |
Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, Muntoni AL, Lutz B, Gessa GL, Marsicano G, Di Marzo V, Pistis M. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiology of Disease. 24: 15-27. PMID 16762556 DOI: 10.1016/J.Nbd.2006.04.010 |
0.846 |
|
| 2006 |
Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. The European Journal of Neuroscience. 23: 2385-94. PMID 16706846 DOI: 10.1111/j.1460-9568.2006.04759.x |
0.835 |
|
| 2006 |
Pistis M, Perra S, Pillolla G, Muntoni A, Melis M. P.6.b.001 The endocannabinoid system in the effects of alcohol on limbic neurons:an in vivo electrophysiological study European Neuropsychopharmacology. 16: S496-S497. DOI: 10.1016/S0924-977X(06)70672-1 |
0.761 |
|
| 2005 |
Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL, Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology. 183: 368-77. PMID 16228194 DOI: 10.1007/s00213-005-0195-0 |
0.834 |
|
| 2005 |
Melis M, Spiga S, Diana M. The dopamine hypothesis of drug addiction: hypodopaminergic state. International Review of Neurobiology. 63: 101-54. PMID 15797467 DOI: 10.1016/S0074-7742(05)63005-X |
0.721 |
|
| 2005 |
Pistis M, Muntoni AL, Pillolla G, Perra S, Cignarella G, Melis M, Gessa GL. Gamma-hydroxybutyric acid (GHB) and the mesoaccumbens reward circuit: evidence for GABA(B) receptor-mediated effects. Neuroscience. 131: 465-74. PMID 15708487 DOI: 10.1016/j.neuroscience.2004.11.021 |
0.835 |
|
| 2004 |
Melis M, Perra S, Muntoni AL, Pillolla G, Lutz B, Marsicano G, Di Marzo V, Gessa GL, Pistis M. Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 10707-15. PMID 15564588 DOI: 10.1523/Jneurosci.3502-04.2004 |
0.85 |
|
| 2004 |
Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry. 56: 86-94. PMID 15231440 DOI: 10.1016/j.biopsych.2004.05.006 |
0.846 |
|
| 2004 |
Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 53-62. PMID 14715937 DOI: 10.1523/JNEUROSCI.4503-03.2004 |
0.836 |
|
| 2004 |
Pistis M, Perra S, Pillolla G, Melis M, Gessa GL, Muntoni AL. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology. 46: 115-25. PMID 14654103 DOI: 10.1016/j.neuropharm.2003.08.003 |
0.845 |
|
| 2002 |
Melis M, Camarini R, Ungless MA, Bonci A. Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 2074-82. PMID 11896147 DOI: 10.1523/Jneurosci.22-06-02074.2002 |
0.766 |
|
| 2001 |
Pistis M, Porcu G, Melis M, Diana M, Gessa GL. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation. The European Journal of Neuroscience. 14: 96-102. PMID 11488953 DOI: 10.1046/j.0953-816X.2001.01612.x |
0.845 |
|
| 2000 |
Melis M, Gessa GL, Diana M. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 24: 993-1006. PMID 11041539 DOI: 10.1016/S0278-5846(00)00119-6 |
0.819 |
|
| 2000 |
Fattore L, Melis M, Diana M, Fratta W, Gessa G. The cyclo-oxygenase inhibitor nimesulide induces conditioned place preference in rats. European Journal of Pharmacology. 406: 75-7. PMID 11011036 DOI: 10.1016/S0014-2999(00)00665-8 |
0.788 |
|
| 2000 |
Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 642-9. PMID 10788763 DOI: 10.1016/S0893-133X(00)00087-7 |
0.854 |
|
| 2000 |
Melis M, Diana M, Gessa GL. Cyclo-oxygenase-inhibitors increase morphine effects on mesolimbic dopamine neurons. European Journal of Pharmacology. 387: R1-3. PMID 10633170 DOI: 10.1016/S0014-2999(99)00799-2 |
0.82 |
|
| 1999 |
Diana M, Muntoni AL, Pistis M, Melis M, Gessa GL. Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal. The European Journal of Neuroscience. 11: 1037-41. PMID 10103095 DOI: 10.1046/j.1460-9568.1999.00488.x |
0.831 |
|
| 1999 |
Melis M, Diana M, Gessa GL. Clozapine potently stimulates mesocortical dopamine neurons. European Journal of Pharmacology. 366: R11-3. PMID 10082220 DOI: 10.1016/S0014-2999(98)00934-0 |
0.823 |
|
| 1998 |
Melis M, Gessa GL, Diana M. Clozapine does activate nigrostriatal dopamine neurons in unanesthetized rats. European Journal of Pharmacology. 363: 135-8. PMID 9881580 DOI: 10.1016/S0014-2999(98)00822-X |
0.827 |
|
| 1998 |
Diana M, Melis M, Gessa GL. Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. The European Journal of Neuroscience. 10: 2825-30. PMID 9758152 DOI: 10.1111/j.1460-9568.1998.00292.x |
0.822 |
|
| 1998 |
Diana M, Melis M, Muntoni AL, Gessa GL. Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proceedings of the National Academy of Sciences of the United States of America. 95: 10269-73. PMID 9707636 DOI: 10.1073/pnas.95.17.10269 |
0.852 |
|
| 1998 |
Gessa GL, Melis M, Muntoni AL, Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology. 341: 39-44. PMID 9489854 DOI: 10.1016/S0014-2999(97)01442-8 |
0.845 |
|
| 1998 |
Melis M, Mereu G, Lilliu V, Quartu M, Diana M, Gessa GL. Haloperidol does not produce dopamine cell depolarization-block in paralyzed, unanesthetized rats. Brain Research. 783: 127-32. PMID 9479061 DOI: 10.1016/S0006-8993(97)01316-4 |
0.82 |
|
| 1997 |
Castelli MP, Melis M, Mameli M, Fadda P, Diaz G, Gessa GL. Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Research. Molecular Brain Research. 45: 149-53. PMID 9105683 DOI: 10.1016/S0169-328X(96)00305-1 |
0.628 |
|
| 1996 |
MELIS M, MUNTONI AL, DIANA M, GESSA GL. DIFFERENT MECHANISMS UNDERLIE THE LOCOMOTOR STIMULATION INDUCED BY DOPAMINE AGONISTS AND THE NMDA ANTAGONIST MK-801 Behavioural Pharmacology. 7: 68. DOI: 10.1097/00008877-199605001-00153 |
0.721 |
|
| 1990 |
Argiolas A, Melis MR, Stancampiano R, Mauri A, Gessa GL. Hypothalamic modulation of immunoreactive oxytocin in the rat thymus. Peptides. 11: 539-43. PMID 2381874 |
0.671 |
|
| 1990 |
Argiolas A, Melis MR, Stancampiano R, Gessa GL. Role of calcium in the expression of ACTH-induced stretching, yawning and penile erection. Brain Research Bulletin. 24: 853-6. PMID 2372702 |
0.662 |
|
| 1990 |
Argiolas A, Melis MR, Stancampiano R, Gessa GL. Oxytocin-induced penile erection and yawning: role of calcium and prostaglandins. Pharmacology, Biochemistry, and Behavior. 35: 601-5. PMID 2339153 |
0.666 |
|
| 1990 |
Melis MR, Argiolas A, Stancampiano R, Gessa GL. Effect of apomorphine on oxytocin concentrations in different brain areas and plasma of male rats. European Journal of Pharmacology. 182: 101-7. PMID 2205505 |
0.732 |
|
| 1990 |
Argiolas A, Gessa GL, Melis MR, Stancampiano R, Vaccari A. Effects of neonatal and adult thyroid dysfunction on thymic oxytocin. Neuroendocrinology. 52: 556-9. PMID 2126606 |
0.661 |
|
| 1990 |
Argiolas A, Melis MR, Stancampiano R, Gessa GL. Omega-conotoxin prevents apomorphine- and oxytocin-induced penile erection and yawning in male rats. Pharmacology, Biochemistry, and Behavior. 37: 253-7. PMID 2080187 |
0.702 |
|
| 1989 |
Melis MR, Argiolas A, Stancampiano R, Gessa GL. Oxytocin-induced motor disturbances: relationship with penile erection and yawning. Pharmacology, Biochemistry, and Behavior. 34: 673-5. PMID 2623025 |
0.665 |
|
| 1984 |
Gessa GL, Fratta W, Melis M, Bertolini A, Ferrari W. Hypothalamic ACTH and MSH levels increase in morphine tolerance and decrease after morphine withdrawal. European Journal of Pharmacology. 95: 143-4. PMID 6321202 DOI: 10.1016/0014-2999(83)90280-7 |
0.512 |
|
| Show low-probability matches. |